Zobrazeno 1 - 2
of 2
pro vyhledávání: '"for the STAMPEDE Trial Collaborative Group"'
Autor:
Chris C. Parker, Nicholas D. James, Christopher D. Brawley, Noel W. Clarke, Adnan Ali, Claire L. Amos, Gerhardt Attard, Simon Chowdhury, Adrian Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Clare Gilson, Silke Gillessen, Alex Hoyle, Rob J. Jones, Ruth E. Langley, Zafar I. Malik, Malcolm D. Mason, David Matheson, Robin Millman, Mary Rauchenberger, Hannah Rush, J Martin Russell, Hannah Sweeney, Amit Bahl, Alison Birtle, Lisa Capaldi, Omar Din, Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, Mohammed Kagzi, Anna Lydon, Joe M. O’Sullivan, Sangeeta A. Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Nair Srihari, Jacob Tanguay, Mahesh K. B. Parmar, Matthew R. Sydes, for the STAMPEDE Trial Collaborative Group
Publikováno v:
PLoS Medicine, Vol 19, Iss 6 (2022)
Background STAMPEDE has previously reported that radiotherapy (RT) to the prostate improved overall survival (OS) for patients with newly diagnosed prostate cancer with low metastatic burden, but not those with high-burden disease. In this final anal
Externí odkaz:
https://doaj.org/article/59bd277f4a854b248d9e56e359be5b75
Autor:
Parker, Chris C., James, Nicholas D., Brawley, Christopher D., Clarke, Noel W., Ali, Adnan, Amos, Claire L., Attard, Gerhardt, Chowdhury, Simon, Cook, Adrian, Cross, William, Dearnaley, David P., Douis, Hassan, Gilbert, Duncan C., Gilson, Clare, Gillessen, Silke, Hoyle, Alex, Jones, Rob J., Langley, Ruth E., Malik, Zafar I., Mason, Malcolm D., Matheson, David, Millman, Robin, Rauchenberger, Mary, Rush, Hannah, Russell, J. Martin, Sweeney, Hannah, Bahl, Amit, Birtle, Alison, Capaldi, Lisa, Din, Omar, Ford, Daniel, Gale, Joanna, Henry, Ann, Hoskin, Peter, Kagzi, Mohammed, Lydon, Anna, O’Sullivan, Joe M., Paisey, Sangeeta A., Parikh, Omi, Pudney, Delia, Ramani, Vijay, Robson, Peter, Srihari, Narayanan Nair, Tanguay, Jacob, Parmar, Mahesh K. B., Sydes, Matthew R., for the STAMPEDE Trial Collaborative Group
Publikováno v:
STAMPEDE Trial Collaborative Group, Parker, C C, James, N D, Brawley, C D, Clarke, N W, Ali, A, Amos, C L, Attard, G, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D C, Gilson, C, Gillessen, S, Hoyle, A, Jones, R J, Langley, R E, Malik, Z I, Mason, M D, Matheson, D, Millman, R, Rauchenberger, M, Rush, H, Russell, J M, Sweeney, H, Bahl, A, Birtle, A, Capaldi, L, Din, O, Ford, D, Gale, J, Henry, A, Hoskin, P, Kagzi, M, Lydon, A, O'Sullivan, J M, Paisey, S A, Parikh, O, Pudney, D, Ramani, V, Robson, P, Srihari, N N, Tanguay, J, Parmar, M K B & Sydes, M R 2022, ' Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial ', PLoS Medicine, vol. 19, no. 6, e1003998 . https://doi.org/10.1371/journal.pmed.1003998
BackgroundSTAMPEDE has previously reported that radiotherapy (RT) to the prostate improved overall survival (OS) for patients with newly diagnosed prostate cancer with low metastatic burden, but not those with high-burden disease. In this final analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7eed042b139f7c5cd966c1b7b63924c
https://orca.cardiff.ac.uk/id/eprint/150285/2/pmed.1003998.pdf
https://orca.cardiff.ac.uk/id/eprint/150285/2/pmed.1003998.pdf